This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Myriad Genetics Inc (MYGN)

NASDAQ: Services

Company Income Statement
Jun 2015 Jun 2014 Jun 2013 Jun 2012
Sales 723.10M 778.22M 613.16M 496.00M
Cost of Sales 122.40M 95.38M 70.73M 55.59M
Gross Operating Profit 600.70M 682.83M 542.44M 440.42M
Selling, General, and Administrative Expenses 366.00M 327.10M 251.84M 208.38M
Research & Development 75.50M 67.48M 53.71M 42.65M
Operating Income before D & A (EBITDA) 159.20M 288.26M 236.89M 189.39M
Depreciation & Amortization 25.00M 13.82M 8.89M 9.07M
Interest Income 400.00K 5.40M 5.50M 4.63M
Other Income - Net 300.00K -1.97M -223.00K -407.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 134.90M 277.87M 233.28M 184.54M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income 134.90M 277.87M 233.28M 184.54M
Income Taxes 54.70M 101.64M 86.14M 72.39M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 80.20M 176.22M 147.14M 112.15M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 80.20M 176.22M 147.14M 112.15M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 80.20M 176.22M 147.14M 112.15M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
80.20M 176.22M 147.14M 112.15M
Preferred Dividends
Net Income Available To Common 80.20M 176.22M 147.14M 112.15M
Basic EPS from Continuing Ops. 1.12 2.33 1.82 1.33
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.12 2.33 1.82 1.33
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.12 2.33 1.82 1.33
Basic Normalized Net Income/Share 1.12 2.33 1.82 1.33
EPS fr Continuing Ops. 1.08 2.25 1.77 1.30
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.08 2.25 1.77 1.30
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.08 2.25 1.77 1.30
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.08 2.25 1.77 1.30
Dividends Paid per Share 0.00 0.00 0.00 0.00
MYGN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

MYGN Myriad Genetics Inc

Chart of MYGN

Analysts Ratings for MYGN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 5 5
Moderate Buy 0 0 0 0
Hold 5 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2
GET MYGN ANALYST REPORT

MYGN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs